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Abstract 
Introduction: Chlordimeform, as well as other formamidine pesticides, induce permanent sex- and region-dependent effects on 
development of monoaminergic neurotransmitter systems. These effects could be related to monoamine oxidase (MAO) inhibition. 
However, chlordimeform is a very weak MAO inhibitor, which suggest that other mechanism should be involved. In this regard, 
chlordimeform alters testosterone and estradiol levels in frontal cortex, which lead to a disruption of the enzymes’ expression that 
mediate the synthesis and metabolism of monoaminergic neurotransmitters systems. Therefore, an alteration of these hormones 
and enzymes in the other brain regions altered could also mediate the effects observed.
Objectives and methods: In order to confirm that the formamidines produce permanent alterations of the monoamine neurotrans-
mitter systems, through disruption of sex hormones in the striatum, by alteration of the expression of the enzymes that synthesize 
and/or metabolize these neurotransmitters, we evaluated, in striatum of male and female rats, the effect on  the levels of testostero-
ne and estradiol at 11 days of age, as well as the expression of MAO, COMT, BDH, TH, TRH, and AD enzymes at 60 days of age 
after maternal exposure to chlordimeform (5 mg / kg body weight).
Results: Chlordimeform induced a significant decrease in testosterone and estradiol levels in striatum of rats at 11 days of age. 
We observed sex interaction with treatment in the content of T and E2. We determined a bigger increase in the expression of BDH 
[44,65% (P<0,001)] enzyme in females than in males. Chlordimeform treatment did not alter the expression of MAO and AD enzy-
mes, but decreased the expression of the enzymes COMT, BDH, TH and TRH in both males and females.
Conclusions: The present findings indicate that after maternal exposure to formamidines, in general, and chlordimeform, in parti-
cular, a permanent alteration of monoaminergic neurotransmitters, through alteration of the enzymes that synthetize these neuro-
transmitters, mediated by sex hormones disruption, in striatum, is induced.
Keywords: Chlordimeform; formamidines; neurodevelopmental toxicity; COMT; BDH; TH; TRH; rats; human risk assessment 
Resumen
Introducción: El clordimeformo, así como otros plaguicidas formamidínicos, induce alteraciones permanentes de los sistemas 
de neurotransmisores monoaminérgicos de forma región y sexo dependiente. La inhibición de la monoamino oxidasa (MAO) por 
parte de estos compuestos, podría mediar estos efectos. Sin embargo, el clordimeformo es un inhibidor muy débil de la MAO lo 
que sugiere que otro mecanismo debería estar implicado. En este sentido, se ha descrito que el clordimeformo altero los niveles 
de las hormonas testosterona y estradiol en la corteza frontal, lo que condujo a la alteración de la expresión de las enzimas que 
sintetizan y metabolizan estos neurotransmisores. Por lo tanto, una alteración de estas hormonas y enzimas en las otras regiones 
afectadas podría también mediar los efectos observados en las mismas.
Objetivos y métodos: Con el objetivo de confirmar que las formamidinas produce alteraciones permanentes de los neurotransmi-
sores monoaminérgicos, a través de la disrupción de las hormonas sexuales a nivel del cuerpo estriado por alteración de la expre-
sión de las enzimas que sintetizan y/o metabolizan estos neurotransmisores, se evaluaron los efectos, en el cuerpo estriado de ratas 
macho y hembra, sobre los niveles de testosterona y estradiol a los 11 días de edad, así como sobre la expresión de las enzimas 
MAO, COMT, BDH, TH , TRH, y AD a los 60 días de edad tras la exposición maternal al clordimeformo (5 mg/kg de peso corporal). 
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Resultados: El clordimeformo indujo una disminución significativa de los niveles de testosterona y estradiol en el cuerpo estriado 
de las ratas descendientes a la edad de 11 días. Se observó una interacción por sexo con el tratamiento en el contenido de T 
y E2. Además se observó una mayor expresión de la enzima BDH [44,65% (P<0,001)] en las hembras que en los machos. El 
tratamiento con clodimeformo no alteró la expresión de las enzimas MAO y AD, pero indujo una disminución en la expresión de las 
enzimas COMT, BDH, TH y TRH tanto en machos como en hembras.
Conclusiones: Los presentes resultados indican que las formamidinas, en general, y el clordimeformo, en particular, inducen, tras 
la exposición maternal, una alteración permanente de los sistemas de neurotransmisores monoaminergicos en el cuerpo estriado, 
a través de la alteración de las enzimas que metabolizan y sintetizan estos neurotransmisores, mediada por la alteración de las 
hormonas sexuales.
Palabras clave: Clordimeformo; formamidinas; neurotoxicidad en el desarrollo; testosterona; estradiol; COMT; BDH; TH; TRH; 
ratas; evaluación del riesgo para el hombre. 
Formamidine pesticides as amitraz have been described 
to produce permanent alterations on the development of 
central nervous system (CNS) such as those that affect 
monoamine neurotransmitter systems1. Chlordimeform [N2-
(4-chloro-o-tolyl)-N1.N1-dimethylformamidine] (Figure 1), 
another member of formamidine pesticides family, has also 
been reported to induce permanent alterations of serotonin-
ergic, noradrenergic and dopaminergic systems in a region- 
and a sex-dependent way2,3. 
The mechanisms by which these effects occur are not 
completely understood. Monoaminergic neurotransmitters 
play a role during development, defined as “morphoge-
netic”4-7. Changes in catecholamines levels during brain 
development may induce both structural and functional 
alterations8. Formamidines have been reported to inhibit 
monoamine oxidase (MAO)9-10, which participates in meta-
bolic inactivation of the neurotransmitters serotonin (5-HT), 
norepinephrine (NE), and dopamine (DA). Therefore, this 
action could mediate the effects observed on monoamin-
ergic neurotransmitters. However, chlordimeform is a very 
weak MAO inhibitor, which suggest other mechanisms are 
involved in these effects. 
Otherwise, formamidines are endocrine disruptors and 
particularly, chlordimeform and amitraz have been report-
ed to alter serum hormone levels19, 20. Changes in NE, 
DA and 5-HT and its metabolites levels observed in rats’ 
brain after formamidines exposure could be attributed to 
a possible effect on sex steroid hormones that modulate 
the expression of enzymes such as tyrosine hydroxylase 
(TH), dopamine-β-hydroxylase (DBH), tryptophan hydrox-
ylase (TRH), MAO, catechol-O-metyltransferase (COMT), 
aldehyde dehydrogenase (AD), aldehyde reductase (AR) 
required for synthesis and metabolism of these neuro-
transmitters11-18. In this regard, after prenatal and postnatal 
exposure to chlordimeform, a disruption in testosterone 
and estradiol levels in frontal cortex was observed, which 
lead to changes in the expression of TH and TRH21. Thus, 
these mechanisms could explain chlordimeform’s, as well 
as other formamidine pesticides’, effects observed on 
monoaminergic neurotransmitters systems.
Therefore, we performed a study to establish if maternal 
exposure to chlordimeform during gestation and lactation 
induces permanent alterations on the enzymes that syn-
thetize and metabolize 5-HT, NE and DA neurotransmitters 
in striatum, at adult age, through sex hormones disruption, 
which could explain the effect observed on these neuro-
transmitters in a sex- and region-dependent way. Chlordi-
meform was chosen because it is the most representa-
tive compound of formamimidines family, which presents 
a very low inhibition of MAO, allowing us to study more 
clearly whether the permanent changes observed on lev-
els of these neurotransmitters are due to an alteration of 
the enzymes that catalyze the synthesis and metabolism 
of these neurotransmitter rather than to MAO inhibition.
Materials and methods 
Biological material 
All experiments were performed in accordance with Euro-
pean Union guidelines (2003/65/CE) and Spanish regula-
tions (BOE 67/8509-12, 1988) regarding the use of lab-
oratory animals. Eight pregnant Wistar rats were housed 
individually in polycarbonate cages and were assigned 
randomly to two experimental groups: a chlordimeform 
treatment group (n = 4) and a control group (n = 4).
Test Chemical and Treatment
Chlordimeform (Sigma, Madrid, Spain) was dissolved in 
corn oil to provide fast and complete absorption and was 
administered orally by gavage in a volume of 2 mg/ml. 
The animals received, daily, chlordimeform at the dose of 
5 mg/kg on days 6 to 21 of pregnancy (GD 6-21) and on 
days 1 to 10 of lactation (PN 1-10). Control dams received 
vehicle (corn oil 2.5 ml/kg) on the same schedules. Dose 
of chlordimeform was selected based on a previous pre-
Figure 1: Chlodimeform chemical structure (C10H13Cl N2).
Cl N= CH - N
CH3
CH3
CH3
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liminary study that indicated that this dose was the higher 
one that did not cause weight loss or mortality, reduction 
of food or water intake as well as did not induce haema-
tological modifications or other clinical histopathological 
signs of overt toxicity. None of the prenatal or postnatal 
treatment evoked a significant change in weight of any of 
the brain regions on PN 60 (data not shown).
Dams were examined daily throughout the gestation and 
lactation periods for mortality, general appearance and be-
haviour. The maternal body weights were measured on 
GD 1, GD 5, GD 6, GD 15 and GD 20. Food and water 
consumption during pregnancy, length of gestation, litter 
size and sex ratio were also assessed. 
On PN1, all litters were examined externally, sexed and 
weighed. Litters were organized in groups of twenty-four 
pups, twelve males and twelve females. Litters were 
weighed at PN 1, PN 7, PN14 and PN 21. The offspring 
were weaned on lactation day 21 and were maintained 
in appropriate conditions, housed individually and with-
out any treatment with full access to food and water until 
adult age. The study was organized in treated groups of 
six males and six females randomly selected respectively 
from the dams’ litters exposed to chlordimeform, and con-
trol groups of six males and six female’s pups randomly 
selected respectively from the control dams’ litters.
At PN11, for the analysis of brain’s testosterone and estra-
diol levels and at PN 60, for the analysis of MAO A, MAO 
B, COMT, BDH, AD, TH and TRH gene expression, male 
and female rats from control and treated groups (pups from 
control dams, and pups from dams exposed to chlordi-
meform, respectively) were sacrificed by decapitation. The 
brain was removed quickly and the striatum was a rapidly 
dissected out at 4ºC22, since this brain region was previ-
ously describe to present sex differences in the effect ob-
served on these neurotransmitters systems and to be one 
of the most affected2,3. Tissues were rapidly weighed and 
stored at -80ºC until analysis. All data were collected by ex-
perimenters blind to the treatment condition of the offspring.
Estradiol and testosterone quantification
Estradiol and testosterone content were measured in stri-
atum from treated animals in order to determine whether 
sex hormones are altered by chlordimeform exposure. 
Estradiol and testosterone content in the striatum was 
measured using an enzyme immunoassay kit (Estradiol 
EIA Kit, Cayman Chemical Company, MI, USA), accord-
ing to the manufacturer’s instruction. Tissues were ho-
mogenized in 300 μl of an equal mixture of ethyl acetate 
and 0.1 M phosphate-buffered saline. The homogenates 
were centrifuged at 21,000 g for 15 min at 4ºC. The re-
sulting mixture was then incubated in a MeOH/dry ice 
bath to solidify the aqueous phase (bottom) and the or-
ganic phase was eluted into a new tube. The ethyl ace-
tate portion was collected and dried. The dried material 
was reconstituted in 120 μl EIA buffer, and 100 μl of the 
sample was used for EIA at duplicate. ELISA values were 
obtained (pg/ml) and corrected for weigh tissue (mg/ml), 
producing a final unit of pg/mg and presented as a per-
centage of the untreated control.
Real-time PCR analysis
The MAOA, MAOB, COMT, AD, TH, TRH and DBH ex-
pression was measured in striatum tissue from control and 
chlordimeform treated animals in order to determine wheth-
er chlordimeform, through sex hormones disruption, alters 
permanently the expression of these enzymes. Total RNA 
was extracted using the Trizol Reagent method (Invitrogen, 
Madrid, Spain). The final RNA concentration was determined 
using a Nanodrop 2000 spectrophotometer (Thermo Fisher 
Scientific, Madrid, Spain), and the quality of total RNA sam-
ples was assessed using an Experion LabChip (Bio-Rad, 
Madrid, Spain) gel. First-strand cDNA was synthesized with 
1000 ng of cRNA by using a PCR array first strand-synthe-
sis kit (C-02; SuperArray Bioscience, Madrid, Spain) in ac-
cordance with the manufacturer’s instructions and including 
a genomic DNA elimination step and external RNA controls. 
After reverse transcription, QPCR was carried out using 
prevalidated primer sets (SuperArray Bioscience) for mR-
NAs encoding MAOA (PPR46359A), COMT (PPR06789A ), 
AD (PPPR43520B), TH (PPR45220F), TRH (PPR48244A), 
DBH (PPR52652A), and ACTB (PPM02945B). ACTB was 
used as an internal control for normalization. Reactions 
were run on a CFX96 using Real-Time SYBR Green PCR 
master mix PA-012 (SuperArray Bioscience). The thermo-
cycler parameters were 95°C for 10 minutes, followed by 
40 cycles of 95°C for 15 seconds and 72°C for 30 sec-
onds. Relative changes in gene expression were calculated 
using the Ct (cycle threshold) method. The expression data 
are presented as actual change multiples23. 
Data analysis
Statistical analysis of data was performed using a Stat-
graphics software, version Plus 4.1 for windows. Values 
are expressed as mean ± S.E.M. obtained from 12 an-
imals, six males and six females, in each group (control 
and treated groups). For values combined for males and 
females, a two-way ANOVA with treatment × sex interac-
tion was the initial test used. Where a significant treatment 
× sex interaction was detected, a separate Student’s t test 
was carried out for each sex. The results were considered 
significant at P<0.05. Results significantly different from 
controls are also presented as change from control (%).
Results 
Estradiol and testosterone quantification
Oral treatment with chlordimeform to dams during the ges-
tation period from day 6 to day 21 and during lactation from 
day 1 to day 10 affected the content of T and E2 in the 
striatum region of offspring rats at the age of 11 days. The 
content of T (ng/g tissue) in the region of striatum in the 
control group and treated group is presented in table I. 
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The content of E2 (ng/g tissue) in the region of the striatum 
of the control group and the treated group is presented in 
table II. The results expressed in tables I and II show 
that in 11 days old rats treated during gestation days 6-21 
and during lactation days 1-10 through their mothers, a 
statistically significant loss of E2 and T content in the stri-
atum compared to control animals was produced. A sex 
interaction with treatment in the content of T and E2 was 
observed (Figure 2). In striatum, the loss observed of E2 
content was 48,01% (P<0,001) and 58,95% (P<0,001) in 
males and females, respectively, and the loss in the con-
tent of T was 17,71% (P<0,001) and 28,50% (P<0,001) in 
males and females, respectively (Figure 2). 
Real-time PCR analysis
Oral treatment with chlordimeform to dams during the ges-
tation period from day 6 to day 21 and during lactation from 
day 1 to day 10 affected the COMT, BDH, TH and TRH 
gene expression of offspring rats at the age of 60 days. In 
60 days old rats treated during gestation days 6-21 and 
during lactation days 1 to 10 a decrease in the expression 
of COMT [23,35% (P<0,01)], BDH [26,15% (P<0,01) and 
60,64% (P<0,001) in males and females, respectively], TH 
[29,46% (P<0,01)] and TRH [43,24% (P<0,01)] enzymes 
in striatum with respect to control animals was observed. 
No effect on gene expression of MAO, and AD enzymes 
was observed (Figure 3). A sex difference in BDH gene 
expression was observed, being higher the expression of 
BDH [44,65% (P<0,001)] enzyme in female than in male 
rats (Figure 4).
Discussion 
Chemical exposure of dams during pregnancy or lacta-
tion could induce developmental neurotoxic effects that 
include alterations in behaviour, neurohistology, neuro-
chemistry and/or gross dysmorphology of CNS, which 
are manifest in the adulthood. Previous studies described 
that formamidines induce permanent alteration in devel-
oping monoamine neurotransmitter systems in a sex- and 
region-dependent way1-3. Specifically, chlordimeform has 
been reported to induce an alteration of 5-HT, DA and NE 
neurotransmitters and their metabolites in a sex-depend-
ent way in only the regions of frontal cortex, striatum and 
hippocampus2,3. The mechanism by which these perma-
nent effects on monoaminergic systems take place is not 
completely understood, but monoamine neurotransmitters 
Table I: Tissue T (pg/ml) content determined in striatum from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw orally on days 
6 to 21 of pregnancy and 1 to 10 of lactation). 
Values are mean ± S.E.M.; control animals (n= 6 males, n= 6 females); treated group (n= 6 males, n= 6 females).
Statistical significance is reported for the ***P<0.001 levels compared with the control group.
Frontal Cortex
 Animal Control group Treated group Control group Treated group
  Males Males Females Females
 1 201,87 164,87 213,69 152,84
 2 210,55 175,98 206,77 143,98
 3 209,70 172,79 209,31 156,42
 4 213,73 178,56 201,71 147,33
 5 205,96 169,45 216,76 149,87
 6 215,91 173,28 206,68 146,87
 Mean ± 209,62±1,88*** 172,49±1,97*** 209,15±2,20*** 149,55±1,84***
 SEM  (-17,71%)  (-28,50%)
Table II: Tissue E2 (pg/ml) content determined in striatum from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw orally on 
days 6 to 21 of pregnancy and 1 to 10 of lactation).  
Values are mean ± S.E.M.; control animals (n= 6 males, n= 6 females); treated group (n= 6 males, n= 6 females).
Statistical significance is reported for the ***P<0.001 levels compared with the control group.
Frontal Cortex
 Animal Control group Treated group Control group Treated group
  Males Males Females Females
 1 67,84 36,87 60,76 21,87
 2 64,88 38,33 68,94 24,81
 3 59,98 29,76 59,64 27,98
 4 63,85 35,91 68,64 30,34
 5 68,98 31,94 63,81 26,95
 6 73,29 34,55 62,76 25,93
 Mean ± 66,47±1,88*** 34,56±1,30*** 64,09±1,60*** 26,31±1,18***
 SEM  (-48,01%)  (-58,95%)
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regulate brain development prior to assuming their roles as 
transmitters in the mature brain24-26, thus any circumstance 
that affects these neurotransmitters in the developing brain 
can alter the final structure and function of that brain. Since 
the endogenous levels of 5-HT, DA and NE are highly 
regulated by MAO, any change in this enzyme can pro-
foundly affect the developing brain. In this regard, it has 
been reported that gestational exposure to MAO inhibitors 
clorgyline and deprenyl produces in offspring at 30 days 
of age, a significant reduction of serotonergic innervation 
particularly in the frontal cortex27, but not in the dopamin-
ergic and noradrenergic innervation, which suggests that 
besides MAO inhibition other mechanism should be im-
plicated in the alteration observed. However, chlordime-
form is a very weak MAO inhibitor28-30, but presents similar 
permanent regional and sexual dependent effects than 
amitraz, which is a potent MAO inhibitor9. These data sug-
gest that MAO inhibition could not produce the alterations 
in monoaminergic neurotransmitters systems observed, 
confirming that other mechanisms are involved. 
Otherwise, steroids play a role in the development of cat-
echolamine systems31-34, and play a critical role in mam-
malian brain developmental of both genders35. The pres-
ent study shows that prenatal and postnatal exposure 
to chlordimeform (5 mg/kg bw orally on days 6 to 21 of 
pregnancy and 1 to 10 of lactation) was not able to induce 
maternal toxicity, since during pregnancy maternal weight 
gain of treated rats was not modified. However, chlordime-
form administered during pregnancy and lactation leads to 
a decrease in T and E2 levels at PN11, which is the criti-
cal period of time when sexual differentiation takes place, 
in male and female rats’ brain. This treatment produced 
also a permanent reduction of the COMT, BDH, TH and 
TRH gene expression, which catalyse the synthesis and 
metabolism of monoaminergic neurotransmitters, at 60 
days of age in male and female rats’ striatum. Previously, 
chlordimeform has been reported to decrease T and E2 
levels at PN11 and a reduction of the TH and TRH gene 
expression at PN60 in frontal cortex20, which support the 
effect observed. The sex and region differences in the en-
zymes altered in this region correspond with the alteration 
observed on the monoaminergic neurotransmitters in this 
region, which could explain the effect observed.
Sex hormones’ effect on monoaminergic and indolamin-
ergic neurotransmitters in CNS includes synthesis, ve-
sicular and/or synaptic release and metabolism regula-
tion36.The sex hormones provenance in the brain, could 
be from gonads or from endogenous synthesis, as pre-
viously described, whose contribution to the final effect 
depends on the region and sex steroid hormone37-40. 
Estradiol alters the levels of enzymes that synthesize 
DA, NE and 5HT, as well as those that degrade these 
Figure 2: Tissue T and E2 (pg/ml) content determined in striatum from male and female rats at 11 days of age treated with vehicle or chlordimeform (5 mg/kg bw orally 
on days 6 to 21 of pregnancy and 1 to 10 of lactation). 
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neurotransmitters12,14,16,41-42. E2 elevated mRNA levels of 
TH, the first and major rate limiting enzyme in catechola-
mine biosynthesis42 and enhanced TRH mRNA expres-
sion12. In addition, T and DHT regulated the synthesis 
and metabolism of monoamines17. In this sense, T and 
DHT increased TH protein and COMT, MAO-A and 
MAO-B mRNAs15. In the same way, DHT decreased 
neurotransmitter turnover of DOPAC/DA, MHPG/NE, 
and 5-HIAA/5-HT of gonadectomized animals13. These 
previous data support that the disruption in sex hor-
mones observed, mediate the effects observed on 
these enzymes after chlordimeform treatment, and so, 
on the monoaminergic neurotransmitters. However, we 
cannot rule out that an alteration of monoaminergic neu-
rotransmitters transporters, which have been shown to 
be regulated by estradiol43-46, might contribute to the ef-
fect observed.
Furthermore, other possible mechanisms that may con-
tribute to the permanent alterations observed on mono-
aminergic neurotransmitters systems could be a direct 
action of chlordimeform on neuronal cell replication, 
differentiation, axonogenesis and synaptogenesis and 
functional development of neurotransmitter systems, ef-
fects that could result in behavioural alterations observed 
in previous studies after developmental exposure to 
chlordimeform47. The loss of dopaminergic, serotonin-
ergic and noradrenergic projections could also play an 
important role in the behavioural and motor alterations. In 
this regard, striatum participates in the regulation of mo-
tor control and learning and memory processes, among 
other actions48-51, thus, it could be considered that these 
processes could be compromised by exposure during 
gestation and lactation to formamidines. Moreover, neu-
ral functions like affect, anxiety, mood, fear and cognitive 
function are modulated by estradiol, predominantly en-
hancing learning and memory, in addition to its well-doc-
umented role in reproduction52. Therefore, the neurotoxic 
effects observed by chlordimeform or amitraz exposure 
such as behavioral effects as hyperreactivity to exter-
nal stimuli, aggressiveness, and motor incoordination, 
among others47,53, could be mediated by the alteration 
observed in these neurotransmitters. Neurofunctional 
disorders such as schizophrenia, aggressive behaviour, 
autism spectrum disorder and attention deficit hyper-
activity disorder has been associated with imbalance in 
dopamine and other neurotransmitters in the developing 
brain54-59, so these alterations could also lead to devel-
opment of some of these neurological disorders after 
formamidines exposure. Further studies are needed to 
test whether these other mechanisms described could 
be involved in the effects observed and to confirm that 
Figure 3: Sex difference results from real-time PCR targeting MAO, COMT, BDH, AD, TH y TRH genes after chlordimeform treatment in male and female rats. MAO, 
COMT, BDH, AD, TH y TRH gene expression was compared to male rats results. Each bar represents mean ± SD of 6 samples. Levels were measured using QPCR. 
ACTB was used as an internal control. ***p ≤ 0.001,**p ≤ 0.01, significantly different from males. 
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alteration of these neurotransmitter systems is the cause 
of some of these dysfunctions. 
DA, 5-HT and NE systems alterations observed after 
chlordimeform exposure in the frontal cortex, striatum, and 
hippocampus were similar between them2,3. Moreover, the 
testosterone and estradiol hormone levels disruption pro-
duced after chlordimeform exposure in the frontal cortex 
and striatum was also similar, as well as the effect on mon-
oaminergic neurotransmitters regulating enzymes gene ex-
pression, except for COMT and BDH. These results sug-
gests that the mechanisms through which monoaminergic 
neurotransmitters systems are altered in the brain regions 
affected after chlordimeform exposure is produced by the 
alteration in the expression of these enzymes, mediated 
through sex hormones disruption. In addition, the effects 
observed on DA, 5-HT and NE systems after amitraz 
exposures were also the same as those observed after 
chlordimeform exposure1, suggesting that these mecha-
nisms are the same in chlordimeform and amitraz in par-
ticular, and in formamidines in general. Further studies are 
needed to confirm whether this mechanism and others, 
probably involved in these effects, are the same in all brain 
regions studied and for all formamidines.
Figure 4: Results from real-time PCR targeting MAO, COMT, BDH, AD, TH y TRH genes after chlordimeform treatment in male and female rats. MAO, COMT, BDH, 
AD, TH y TRH gene expression was compared to controls. Each bar represents mean ± SD of 6 samples. Levels were measured using QPCR. ACTB was used as an 
internal control. ***p ≤ 0.001, **p ≤ 0.01 significantly different from controls. 
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
Veh Veh
MAO A COMT
CMZ CMZ
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
Veh Veh
MALES BDH FEMALES BDH
CMZ CMZ
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
Veh Veh
AD TH
CMZ CMZ
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
m
R
N
A
 le
ve
ls
(%
 C
on
tr
ol
)
150
100
50
0
Striatum
Veh
TRH
CMZ
***
**
**
***
**
20 Medicina Balear 2017; 32 (2): 13-22
Paula Moyano et al. Striatal alteration of monoaminergic neurotransmitters systems in rats, after prenatal and postnatal exposure to chlordimeform, through testosterone and estradiol disruption
1. Del Pino J, Martínez MA, Castellano VJ, Ramos E, Martínez-larrañaga 
MR, Anadón A. Effects of prenatal and postnatal exposure to amitraz on 
norepinephrine, serotonin and dopamine levels in brain regions of male 
and female rats. Toxicology. 2011; 287(1-3):145-52.
2. García JM, Alias P, Frejo MT, Anadon MJ, Capo MA, Del Pino J. 
Effects of prenatal and postnatal exposure to chlordimeform on sero-
tonin levels in brain regions of adult’s male and female rats. Medicina 
Balear. 2015; 30(1): 21-6
3. García JM, Frejo MT, Anadon MJ, Capo MA, Del Pino J. Permanent 
sexual and regional noradrenergic and dopaminergic systems impair-
ment after prenatal and postnatal exposure to chlordimeform. 2015; 
30(3): 12-8.
4. Buznikov GA, Shmukler YB, Lauder JM. From oocyte to neuron: do 
neurotransmitters function in the same way throughout development. 
Cell. Mol. Neurobiol. 1996; 16(5): 533-59.
5. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH. New evi-
dence for neurotransmitter influences on brain development. Trends 
Neurosci. 1997; 20(6):269-74.
6. Nicotra A, Schatten G. Propranolol, a beta-adrenergic receptor blocker, 
affects microfilament organization, but not microtubules, during the first 
division in sea urchin eggs. Cell Motil. Cytoskeleton. 1990; 16(3):182-9.
7. Nicotra A, Senatori O. Some characteristics of mitochondrial mo-
noamine oxidase activity in eggs of carp (Cyprinus carpio) and rainbow 
trout (Salmo gairdneri). Comp. Biochem. Physiol. 1989; C92(2):401-4.
8. Lakshmana M, Raju TR. Endosulfan induces small but significant 
changes in the levels of noradrenaline, dopamine and serotonin in the 
developing rat brain and deficits in the operant learning performance. 
Toxicology. 1994; 91(2):139-50.
9. Aziz SA, Knowles CO. Inhibition of monoamine oxidase by the pesti-
cide chlordimeform and related compounds. Nature. 1973; 242:417-8.
10. Bailey BA, Martin RJ, Downer RGH. Monoamine oxidase inhibition 
and brain catecholamine levels in the rat following treatment with chlor-
dimeform. Pest Biochem Physiol. 1982; 17:293-300.
11. De Souza Silva MA, Mattern C, Topic B, Buddenberg TE, Huston 
JP. Dopaminergic and serotonergic activity in neostriatum and nucleus 
accumbens enhanced by intranasal administration of testosterone. Eur 
Neuropsychopharmacol. 2009; 19 (1): 53-63.
12. Donner N, Handa RJ. Estrogen receptor-beta regulates the expres-
sion of tryptophan hydroxylase 2 mRNA within serotonergic neurons of 
the rat dorsal raphe nuclei. Neuroscience. 209; 163: 705-18.
13. Handa RJ, Hejna GM, Lorens SA. Androgen inhibits neurotransmit-
ter turnover in the medial prefrontal cortex of the rat following exposure 
to a novel environment. Brain Res. 1997; 751 (1): 131-8.
14. Luine VN, Rhodes JC. Gonadal hormone regulation of MAO and other 
enzymes in hypothalamic areas. Neuroendocrinology. 1983; 36: 235-41.
15. Purves-Tyson TD, Handelsman DJ, Double KL, Owens SJ, Busta-
mante S, Weickert CS. Testosterone regulation of sex steroid-related 
References
Conclusion 
In summary, our results suggest that the mechanism by 
which the alterations in the development of the monoam-
inergic neurotransmitter systems in striatum is mediated 
through disruption of estradiol and testosterone levels, 
which produced a permanent alteration of the expression 
of some of the enzymes that synthetize and metabolize 
these monoaminergic neurotransmitters. Further studies 
are required to check whether other hormones are also in-
volved in these effects and to determine whether they act 
directly on expression of the affected enzymes or through 
induction of other genes that can regulate their expres-
sion. Otherwise, it should be determined whether there 
is a reduction in innervation in the regions affected that 
could also contribute to the effect observed. Moreover, it 
should be determined if these mechanism are the same in 
all formamidines and in all brain regions affected by them. 
Due to the fact that monoaminergic neurotransmitters dys-
functions are related with appetite, affective, neurological 
and psychiatric disorders, behavioral studies of formami-
dines are also needed to clarify the outcomes of long-term 
alterations in these monoaminergic neurotransmitters sys-
tems. Currently, new formamidine molecules with thera-
peutic application are being developed. Until now, the risk 
assessment of the family of these compounds has been 
taken from the standpoint of carcinogenesis. In view of 
these results and our previous results it might be appro-
priate to reconsider the risk assessment of the members 
of this family based not only on their possible carcinogenic 
effects, but also in the neurotoxic effects during develop-
ment mediated by endocrine disruption. The results re-
ported in this study are of great importance because they 
could lead to a better understanding of the mechanisms 
responsible for producing the neurotoxic alterations and 
should be incorporated into the risk assessment of pesti-
cides formamidines group. 
Compliance with ethical standards 
All experiments were performed in accordance with Eu-
ropean Union guidelines (2003/65/CE) and Spanish reg-
ulations (BOE 67/8509-12, 1988) regarding the use of 
laboratory animals.
Conflict of interest 
The authors declare that there are no conflicts of interest.
Acknowledgments 
The authors would like to thank Margarita Lobo, Profes-
sor of Toxicology from the Universidad Complutense de 
Madrid for her counseling during the preparation of the 
present work.
21Medicina Balear 2017; 32 (2): 13-22
Paula Moyano et al. Striatal alteration of monoaminergic neurotransmitters systems in rats, after prenatal and postnatal exposure to chlordimeform, through testosterone and estradiol disruption
mRNAs and dopamine-related mRNAs in adolescent male rat substan-
tia nigra. BMC Neurosci1. 2012; 3: 95.
16. Scardapane L, Cardinali DP. Effect of estradiol and testosterone 
on catecholmethyl transferase activity of rat superior cervical ganglion, 
pineal gland, anterior hypophysis and hypothalamus. J Neurotrans. 
1977; 40: 81-6.
17. Thiblin I, Finn A, Ross SB, Stenfors C. Increased dopaminergic and 
5-hydroxytryptaminergic activities in male rat brain following long-term 
treatment with anabolic androgenic steroids. Br J Pharmacol. 1999; 
126 (6): 1301-6.
18. Lubbers LS, Zafian PT, Gautreaux C, Gordon M, Alves SE, Correa 
L, Lorrain DS, Hickey GJ, Luine V. Estrogen receptor (ER) subtype ago-
nists alter monoamine levels in the female rat brain. J Steroid Biochem 
Mol Biol. 2010; 122 (5): 310-7.
19. Stoker TE, Goldman JM, Cooper RL, McElroy WK. Influence of 
chlordimeform on alpha-adrenergic receptor-associated mechanisms 
of hormonal regulation in the rat: pituitary and adrenocortical secretion. 
Toxicology. 1991; 69:257-68.
20. García JM, Moyano P, Frejo MT, Anadón MJ, Capó MA, Gómez 
G, Del Pino J. Effects of sex hormones disruption, after prenatal and 
postnatal exposure to chlordimeform, on monoaminergic neurotrans-
mitters systems in female and male rat’s prefrontal cortex. Medicina 
Balear 2016; 31(3): 8-11.
21. Chou CP, Lu SY, Ueng TH.. Modulation of serum concentrations 
and hepatic metabolism of 17 -estradiol and testosterone by amitraz in 
rats. Arch Toxicol. 2008; 82 (10): 729-37.
22. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat 
brain-I. The disposition of [3H] norepinephrine, [3H] dopamine and [3H]
DOPA in various regions of the brain. J. Neurochem. 1966; 13:655-69.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. 
Methods. 2001; 25: 402-8.
24. Whitaker-Azmitia PM. Role of serotonin and other neurotransmitter 
receptors in brain development: basis for developmental pharmacolo-
gy. Pharm. Rev. 1992; 43:553-61.
25. Di Pino G, Moessner R, Lesch KP, Lauder JM, Persico AM. Roles 
for serotonin in neurodevelopment: more than just neural transmission. 
Curr. Neuropharmacol. 2004; 2:403-17.
26. Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but 
not norepinephrine transport during development produces delayed, 
persistent perturbations of emotional behaviours in mice. J. Neurosci. 
2008; 28(1):199-207.
27. Whitaker-Azmitia PM, Zhang X, Clarke C. Effects of gestational 
exposure to monoamine oxidase inhibitors in rats: preliminary beha-
vioral and neurochemical studies. Neuropsychopharmacology. 1994; 
11(2):125-32.
28. Neumann R, Voss G. MAO inhibition, an unlikely mode of action for 
chlordimeform. Experientia. 1977; 33: 23-4.
29. Robinson CP, Smith PW. Lack of involvement of monoamine oxi-
dase inhibition in the lethality of acute poisoning by chlordimeform. J 
Toxicol Environ Health. 1977; 3(3): 565-8.
30. Hollingworth RM. Chemistry, biological activity, and uses of forma-
midine pesticides. Environ Health Perspect. 1976; 14: 57-69.
31. Stewart J, Rajabi H.  Estradiol derived from testosterone in prenatal 
life affects the development of catecholamine systems in the frontal 
cortex in the male rat. Brain Res. 1994; 646(1):157-60.
32. Leret ML, Rua C, Garcia-Montojo M, Lecumberri M, González JC. 
Influence of metyrapone treatment during pregnancy on the develop-
ment and maturation of brain monoaminergic systems in the rat. Acta 
Physiol (Oxf). 2009; 197(4):333-40.
33. Muneoka K, Kuwagata M, Ogawa T, Shioda S. Sex-specific effects 
of early neonatal progesterone treatment on dopamine and serotonin 
metabolism in rat striatum and frontal cortex. Life Sci. 2010; 87(23-
26):738-42.
34. Pappas SS, Tiernan CT, Behrouz B, Jordan CL, Breedlove SM, 
Goudreau JL, Lookingland KJ. Neonatal androgen-dependent sex 
differences in lumbar spinal cord dopamine concentrations and the 
number of A11 diencephalospinal dopamine neurons. J Comp. Neurol. 
2010; 518(13): 2423-36.
35. Konkle ATM, McCarthy MM. Developmental time course of estra-
diol, testosterone, and dihydrotestosterone levels in discrete regions of 
male and female rat brain. Neuroendocrinology. 2011; 152(1): 223-35.
36. Meyers B, D’Agostino A, Walker J, Kritzer MF. Gonadectomy and 
hormone replacement exert region- and enzyme isoform-specific 
effects on monoamine oxidase and catechol-O-methyltransferase acti-
vity in prefrontal cortex and neostriatum of adult male rats. Neuroscien-
ce. 2010; 165(3): 850-62
37. Hojo Y, Higo S, Ishii H, Ooishi Y, Mukai H, Murakami G, Komina-
mi T, Kimoto T, Honma S, Poirier D, Kawato S. Comparison between 
hippocampus-synthesized and circulation-derived sex steroids in the 
hippocampus. Endocrinology. 2009; 150(11): 5106-12.
38. Robel P, Bourreau E, Corpéchot C, Dang DC, Halberg F, Clarke 
C, Haug M, Schlegel ML, Synguelakis M, Vourch C. Neuro-steroids: 
3 beta-hydroxy-delta 5-derivatives in rat and monkey brain. J Steroid 
Bioche. 1987; 27(4-6): 649-55.
39. Zwain IH, Yen SS. Dehydroepiandrosterone: biosynthesis and me-
tabolism in the brain. Endocrinology. 1999; 140(2):880-7.
40. Zwain IH, Yen SS. Neurosteroidogenesis in astrocytes, oligoden-
drocytes, and neurons of cerebral cortex of rat brain. Endocrinolo-
gy.1999; 140(8): 3843-52.
41. Luine VN, Khylchevskaya RI, McEwen BS. Effect of gonadal ste-
roids on activities of monoamine oxidase and choline acetylase in rat 
brain. Brain Res. 1973; 86: 293-306.
42. Serova L, Rivkin M, Nakashima A, Sabban EL. Estradiol stimulates 
gene expression of norepinephrine biosynthetic enzymes in rat locus 
coeruleus. Neuroendocrinology. 2002; 75: 193-200.
43. Meyers B, Kritzer MF. In vitro binding assays using (3)H nisoxeti-
ne and (3)H WIN 35,428 reveal selective effects of gonadectomy and 
hormone replacement in adult male rats on norepinephrine but not do-
pamine transporter sites in the cerebral cortex. Neuroscience. 2009; 
159(1): 271-82.
44. Rivera HM, Oberbeck DR, Kwon B, Houpt TA, Eckel LA. Estradiol 
increases Pet-1 and serotonin transporter mRNA in the midbrain raphe 
nuclei of ovariectomized rats. Brain Res. 2009; 1259: 51-8.
45. Yu PL, Wu CI, Lee TS, Pan WH, Wang PS, Wang SW. Attenuation 
of estradiol on the reduction of striatal dopamine by amphetamine in 
ovariectomized rats. J Cell Biochem 2009; 108(6): 1318-24.
46. Le Saux M, Di Paolo T. Influence of oestrogenic compounds on monoa-
mine transporters in rat striatum. J Neuroendocrinol. 2006; 18(1): 25-32.
22 Medicina Balear 2017; 32 (2): 13-22
Paula Moyano et al.
Striatal alteration of monoaminergic neurotransmitters systems in rats, after prenatal and postnatal exposure to chlordimeform, through testosterone and estradiol disruption
47. Olson KL, Boush GM, Matsumura F. Behavioral effects of perinatal 
exposure of chlodimeform in rats. Bull Environ Contam Toxicol. 1978; 
20(6):760-8.
48. Tewari A, Jog R, Jog MS. The Striatum and Subthalamic Nucleus 
as Independent and Collaborative Structures in Motor Control. Front 
Syst Neurosci. 2016;10:17.
49. González-Burgos I, Feria-Velasco A. Serotonin/dopamine interac-
tion in memory formation. Prog Brain Res. 2008; 172:603-23.
50. Ohno Y, Shimizu S, Tokudome K. Pathophysiological roles of se-
rotonergic system in regulating extrapyramidal motor functions. Biol 
Pharm Bull. 2013; 36(9):1396-400.
51. Dunnet SB, Meldrum A, Muir JL. Frontal-striatal disconnection dis-
rupts cognitive performance of the frontal-type in the rat. Neuroscience. 
2005; 135:1055-65.
52. Jacome LF, Gautreaux C, Inagaki T, Mohan G, Alves S, Lubbers LS, 
Luine V. Estradiol and ERβ agonists enhance recognition memory, and 
DPN, an ERβ agonist, alters brain monoamines. Neurobiol Learn Mem. 
2010; 94(4): 488-98.
53. Florio JC, Sakate M, Palemo-Neto J. Effects of amitraz on motor 
function. Pharmacol Toxicol. 1993; 73: 109-14.
54. Casanova MF, Buxhoeveden D, Gomez J. Disruption in the inhibi-
tory architecture of the cell minicolumn: implications for autism. Neuros-
cientist. 2003; 9: 496-507.
55. Martineau J, Barthelemy C, Jouve J, Muh JP, Lelord G. Monoa-
mines (serotonin and catecholamines) and their derivatives in infantile 
autism: age-related changes and drug effects. Dev. Med. Child Neurol. 
1992; 34: 593-603.
56. Robinson PD, Schutz CK, Macciardi F, White BN, Holden JJ. Ge-
netically determined low maternal serum dopamine beat-hydroxylase 
levels and the etiology of autism spectrum disorders. Am. J. Med. Ge-
net. 2001; 100; 30-6.
57. Volkmar FR. Pharmacological interventions in autism: theoretical 
and practical issues. J. Clin. Child Psychol. 2001; 30: 80-7.
58. Insel TR, Zohar J, Benkelf ATC, Murphy DL. Serotonin in obses-
sions, compulsions, and the control of aggressive impulses. Ann. N. Y. 
Acad. Sci. 1990; 600:574-85.
59. Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity 
and the impulse control disorders. J. Neuropsychiatry  Clin. Neurosci. 
1993; 5(1):9-17.
